India Generic Injectables Market Report 2022-27: Overview, Share, Analysis, Outlook and key Players

According to the latest report by IMARC Group, titled "India Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," The India generic injectables market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2027, exhibiting a CAGR of 12.8% during 2022-2027.

Report Metric

Historical: 2016-2021

Base Year: 2021

Forecast Year: 2022-2027

Download free sample of the report: https://www.imarcgroup.com/india-generic-injectables-market/requestsample

India Generic Injectables Market Industry Definition and Application:

A generic injectable is a drug having the same pharmaceutical composition as its branded counterpart in safety, strength, dosage form, performance, quality, and route of administration. It is cost-effective as generic injectable does not have to undergo animal testing and clinical studies to demonstrate safety and effectiveness. As it also delivers the same amount of active ingredients to the body, the demand for generic injectables is rising across India.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

India Generic Injectables Market Trends and Drivers:

The growing prevalence of chronic diseases, such as cancer, stroke, diabetes, septicemia, influenza and pneumonia, and respiratory and Alzheimer's disease, represents one of the key factors driving the market in India. Moreover, the Government of India is extensively investing in research and development (R&D) activities to support the introduction of innovative generic injectables and provide effective drug administration, thereby enabling faster recovery of patients. This, along with the expanding healthcare industry, is contributing to the growth of the market in the country. In addition, technological advancements in the drug delivery systems, such as the introduction of self-injection devices, are positively influencing the market. Besides this, the increasing number of health insurance companies in the country is offering lucrative growth opportunities to industry investors. Additionally, the rising awareness among the masses about the benefits of using generic injectables is propelling the growth of the market in India. Apart from this, there is a rise in the shortage of branded medicines and the expiry of patents of branded items in the country. This, coupled with the burgeoning life science industry, is catalyzing the demand for generic injectables. Furthermore, the introduction of 3D printing technology in the country that helps manufacture generic drugs with varying release dates and tastes is bolstering the growth of the market. Looking forward, IMARC Group expects the market to reach US$ 4.38 Billion by 2027, exhibiting a CAGR of 12.8% during the forecast period (2022-2027).

Browse full report with TOC: https://www.imarcgroup.com/india-generic-injectables-market

India Generic Injectables Market 2022-2027 Analysis and Segmentation:

The report has segmented the market on the basis on region, therapeutic area, container, distribution channel.

Breakup by Therapeutic Area:

Oncology
Anaesthesia
Anti-infectives
Parenteral Nutrition
Cardiovascular

Breakup by Container:

Vials
Ampoules
Premix
Prefilled Syringes

Breakup by Distribution Channel:

Hospitals
Retail Pharmacy

Breakup by Region:

North India
West and Central India
South India
East India

Related Report by IMARC Group:

Spa Market Report: https://www.imarcgroup.com/spa-market

Biological Safety Cabinet Market Report: https://www.imarcgroup.com/biological-safety-cabinet-market

Thrombectomy Devices Market Report: https://www.imarcgroup.com/thrombectomy-devices-market

Genomics Market Report: https://www.imarcgroup.com/genomics-market

Semiconductor Intellectual Property Ip Market Report: https://www.imarcgroup.com/semiconductor-intellectual-property-market

Cognitive Assessment And Training Market Report: https://www.imarcgroup.com/cognitive-assessment-training-market

Latin America Dry Eye Syndrome Market Report: https://www.imarcgroup.com/latin-america-dry-eye-syndrome-market

Behavioral Rehabilitation Market Report: https://www.imarcgroup.com/behavioral-rehabilitation-market

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.